Lataa...
The antibiotic drug tigecycline: A focus on its promising anticancer properties
Tigecycline (TIG), the first member of glycylcycline bacteriostatic agents, has been approved to treat complicated infections in the clinic because of its expanded-spectrum antibiotic potential. Recently, an increasing number of studies have emphasized the anti-tumor effects of TIG. The inhibitory e...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2016-12-01
|
| Sarja: | Frontiers in Pharmacology |
| Aiheet: | |
| Linkit: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00473/full |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|